What is NOVOCART® Inject?

NOVOCART® Inject is a combination of autologous cartilage cells and an in situ polymerizable hydrogel.. Using NOVOCART Inject®, for suitable indications, circumscribed articular cartilage defects can be biologically reconstructed purely arthroscopically.
The main features of the autologous chondrocyte product NOVOCART Inject® are:

• High vitality
• Individually manufactured for each patient
• Arthroscopic OP procedure
• Use of GMP-compliant manufactured homologous serum
• Use of a high-quality, in situ polymerizable biomaterial subjected to a validated quality control, depending on load
• Capable of synthesizing the important matrix components collagen Type-II and aggrecan 
• Capable of synthesizing important growth and differentiation factors
• Exclusion of over-expression of dedifferentiation markers (collagen Type-I) and of cartilage-destructive inflammation mediators such as Interleukin-1ß
• Manufactured and delivered 3 weeks after cartilage extraction
• No antibiotics or antimycotics